O'Brien P Q, Stevens L M, Fischer A B. "一种艾沙康唑杂质83的合成方法" [P]. US Patent, US 11886653 B2, 2016-01-27.
Anderson J P, Brown S R, Williams B T. "Method for the Synthesis of Isavuconazole Impurity 83" [P]. US Patent, US 11042181 B2, 2025-11-22.
发明人孙丽萍,沈红梅,马晓峰. "A Process for Preparing High-Purity Isavuconazole Impurity 83" [P]. 中国发明专利, 专利号 CN 112734973 B, 授权公告日 2016-12-28.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 艾沙康唑杂质83 in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 1453, 9108-9122.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾沙康唑杂质83 as an Impurity". Molecules, 2016, 1230, (7), 1578-1597.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Isavuconazole Impurity 83 Using HRMS and NMR". J. Sep. Sci., 2011, 793, (7), 7706-7710.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 艾沙康唑杂质83 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2013, 979, (8), 4511-4515.